Literature DB >> 3088302

Abnormalities of cerebral lipids in GM1-gangliosidoses, infantile, juvenile, and chronic type.

T Kasama, T Taketomi.   

Abstract

Cerebral lipids of patients with GM1-gangliosidoses, infantile, juvenile, and chronic type which are caused by deficiency of beta-galactosidase, were examined and compared to each other. The infantile type demonstrated abnormal accumulation of GM1 and asialo-GM1 in contrast with marked decrease in such major cerebral lipids as cholesterol, phospholipids, cerebroside, and sulfatide. It was also noted that significant amounts of such unusual lipids as free fatty acids, GlcCer, LacCer, GbOse3Cer, and GbOse-4Cer plus nLcOse4Cer were found in the brain. These findings pointed out that this infantile type might accompany a severe cerebral dysgenesis with poor myelination. The juvenile type also showed marked increase in GM1 and asialo-GM1, but the decrease in cholesterol, phospholipids, cerebroside, and sulfatide was not so much as the infantile type. These findings along with the occurrence of cholesterol ester suggested that the brain caused progressive demyelination after the immature myelin appeared. An autopsized brain tissue of a male patient who was eventually diagnosed as a case of GM1-gangliosidosis chronic type after his death, showed some accumulation of GM1 and asialo-GM1 particularly in the caudate nucleus and putamen, whereas it showed moderate amounts of GM1 in apparently normal gray and white matters. It seemed that there are no abnormal cerebral lipids except for gangliosides and some neutral glycosphingolipids in the chronic type.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088302

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  6 in total

1.  Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain.

Authors:  Julian R Arthur; Karie A Heinecke; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2011-04-20       Impact factor: 5.922

2.  Lactosylceramide in lysosomal storage disorders: a comparative immunohistochemical and biochemical study.

Authors:  H Hůlková; J Ledvinová; B Asfaw; K Koubek; K Kopriva; M Elleder
Journal:  Virchows Arch       Date:  2005-05-26       Impact factor: 4.064

3.  Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models.

Authors:  J Alroy; U Orgad; R DeGasperi; R Richard; C D Warren; K Knowles; J G Thalhammer; S S Raghavan
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

4.  AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival.

Authors:  Rena C Baek; Marike L D Broekman; Stanley G Leroy; Laryssa A Tierney; Michael A Sandberg; Alessandra d'Azzo; Thomas N Seyfried; Miguel Sena-Esteves
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

5.  Myelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosis.

Authors:  Karie A Heinecke; Adrienne Luoma; Alessandra d'Azzo; Daniel A Kirschner; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2015-02-18       Impact factor: 4.146

6.  Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.

Authors:  Igor Nestrasil; Alia Ahmed; Josephine M Utz; Kyle Rudser; Chester B Whitley; Jeanine R Jarnes-Utz
Journal:  Mol Genet Metab       Date:  2017-12-20       Impact factor: 4.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.